Global and China Contrast-Enhanced Ultrasound Market Size, Status and Forecast 2021-2027

Contrast-Enhanced Ultrasound also known as CEUS, is an ultrasound which use gas filled micro bubbles for the improved visualize blood vessels and organs in the pelvis and abdomen regions such as liver, spleen pancreas, bowel, kidney and bladder.

Market Analysis and Insights: Global Contrast-Enhanced Ultrasound Market
The global Contrast-Enhanced Ultrasound market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Contrast-Enhanced Ultrasound market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Contrast-Enhanced Ultrasound market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Contrast-Enhanced Ultrasound market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Contrast-Enhanced Ultrasound market.

Global Contrast-Enhanced Ultrasound Scope and Market Size
Contrast-Enhanced Ultrasound market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Contrast-Enhanced Ultrasound market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Non-targeted contrast-enhanced ultrasound
Targeted contrast-enhanced ultrasound

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Trivitron Healthcare
Bracco Diagnostic Inc.
Koninklijke Philips N.V.
BK Medical Holding Company, Inc.
Lantheus Medical Imaging, Inc.
GE Healthcare
Daiichi Sankyo Company, Limited
Bristol-Myers Squibb Company
Acusphere, Inc

Frequently Asked Questions